Sign Up Today and Learn More About Mission Bio Stock
Invest in or calculate the value of your shares in Mission Bio or other pre-IPO companies through EquityZen's platform.
Mission Bio Stock (MISB)
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
About Mission Bio Stock
Founded
2012
Headquarters
San Francisco, CA, US
Industries
Data and Analytics, Science and Engineering, Health Care
Mission Bio Press Mentions
Stay in the know about the latest news on Mission Bio
Single Cell Omics Market Soars with Global Investments and Innovation | DataM Intelligence
einpresswire • Jul 25, 2025
Single-Cell Sequencing Market to Hit USD 7,420.8 Million by 2032 Due to Rising Demand for Precision Medicine and Advanced Genomics – SNS Insider
globenewswire • Jun 12, 2025
Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis
biospace • May 07, 2025
Pre-enrichment for single-cell analysis for detecting measurements of residual …
patents • May 04, 2025
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
globenewswire • Apr 08, 2025
Mission Bio Management
Leadership team at Mission Bio
Chief Technology Officer & SVP of Operations
Nigel P. Beard
CFO
Marcel Roche
Join now and verify your accreditation status to gain access to:
- Mission Bio Current Valuation
- Mission Bio Stock Price
- Mission Bio Management
- Available deals in Mission Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Mission Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Mission Bio Revenue and Financials
- Mission Bio Highlights
- Mission Bio Business Model
- Mission Bio Risk Factors
- Mission Bio Research Report from SACRA Research
Trading Mission Bio Stock
How to invest in Mission Bio stock?
Accredited investors can buy pre-IPO stock in companies like Mission Bio through EquityZen funds. These investments are made available by existing Mission Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Mission Bio stock?
Shareholders can sell their Mission Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
